140 related articles for article (PubMed ID: 12725353)
1. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs.
Song X; Srinivasan A; Plaut D; Perl TM
Infect Control Hosp Epidemiol; 2003 Apr; 24(4):251-6. PubMed ID: 12725353
[TBL] [Abstract][Full Text] [Related]
2. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607
[TBL] [Abstract][Full Text] [Related]
3. Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia.
Caballero-Granado FJ; Becerril B; Cuberos L; Bernabeu M; Cisneros JM; Pachón J
Clin Infect Dis; 2001 Feb; 32(4):587-94. PubMed ID: 11181122
[TBL] [Abstract][Full Text] [Related]
4. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges.
Cosgrove SE; Qi Y; Kaye KS; Harbarth S; Karchmer AW; Carmeli Y
Infect Control Hosp Epidemiol; 2005 Feb; 26(2):166-74. PubMed ID: 15756888
[TBL] [Abstract][Full Text] [Related]
5. Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs.
Primo MG; Guilarde AO; Martelli CM; Batista LJ; Turchi MD
Braz J Infect Dis; 2012; 16(6):503-9. PubMed ID: 23158266
[TBL] [Abstract][Full Text] [Related]
6. Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? The Johns Hopkins SICU Study Group.
Mainous MR; Lipsett PA; O'Brien M
Arch Surg; 1997 Jan; 132(1):76-81. PubMed ID: 9006556
[TBL] [Abstract][Full Text] [Related]
7. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality.
Lautenbach E; Bilker WB; Brennan PJ
Infect Control Hosp Epidemiol; 1999 May; 20(5):318-23. PubMed ID: 10349947
[TBL] [Abstract][Full Text] [Related]
8. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.
Lee NY; Lee HC; Ko NY; Chang CM; Shih HI; Wu CJ; Ko WC
Infect Control Hosp Epidemiol; 2007 Jun; 28(6):713-9. PubMed ID: 17520546
[TBL] [Abstract][Full Text] [Related]
9. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study.
Wisplinghoff H; Cornely OA; Moser S; Bethe U; Stützer H; Salzberger B; Fätkenheuer G; Seifert H
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):905-11. PubMed ID: 14700405
[TBL] [Abstract][Full Text] [Related]
11. [Outbreak of vancomycin-resistant enterococci in a surgical intensive care unit].
Szabó M; Bozó A; Soós S; Darvas K; Harsányi L; Csomós Á
Orv Hetil; 2015 May; 156(19):779-84. PubMed ID: 26039917
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center.
Lodise TP; McKinnon PS; Tam VH; Rybak MJ
Clin Infect Dis; 2002 Apr; 34(7):922-9. PubMed ID: 11880957
[TBL] [Abstract][Full Text] [Related]
13. Attributable mortality of nosocomial Acinetobacter bacteremia.
Grupper M; Sprecher H; Mashiach T; Finkelstein R
Infect Control Hosp Epidemiol; 2007 Mar; 28(3):293-8. PubMed ID: 17326019
[TBL] [Abstract][Full Text] [Related]
14. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.
DiazGranados CA; Jernigan JA
J Infect Dis; 2005 Feb; 191(4):588-95. PubMed ID: 15655783
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes.
Pelz RK; Lipsett PA; Swoboda SM; Diener-West M; Powe NR; Brower RG; Perl TM; Hammond JM; Hendrix CW
Intensive Care Med; 2002 Jun; 28(6):692-7. PubMed ID: 12107672
[TBL] [Abstract][Full Text] [Related]
17. Influence of matching for exposure time on estimates of attributable mortality caused by nosocomial bacteremia in critically ill patients.
Blot S; De Bacquer D; Hoste E; Depuydt P; Vandewoude K; De Waele J; Benoit D; De Schuijmer J; Colardyn F; Vogelaers D
Infect Control Hosp Epidemiol; 2005 Apr; 26(4):352-6. PubMed ID: 15865270
[TBL] [Abstract][Full Text] [Related]
18. Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort.
Butler AM; Olsen MA; Merz LR; Guth RM; Woeltje KF; Camins BC; Fraser VJ
Infect Control Hosp Epidemiol; 2010 Jan; 31(1):28-35. PubMed ID: 19951200
[TBL] [Abstract][Full Text] [Related]
19. Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis.
Odetola FO; Gebremariam A; Freed GL
Pediatrics; 2007 Mar; 119(3):487-94. PubMed ID: 17332201
[TBL] [Abstract][Full Text] [Related]
20. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance.
Morgan J; Meltzer MI; Plikaytis BD; Sofair AN; Huie-White S; Wilcox S; Harrison LH; Seaberg EC; Hajjeh RA; Teutsch SM
Infect Control Hosp Epidemiol; 2005 Jun; 26(6):540-7. PubMed ID: 16018429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
